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a b s t r a c t
The silver ion (Ag(I)) has well established antimicrobial properties and is widely used in a variety of anti-
bacterial ointments and plasters for the control of wound infections. Wounds are frequently colonised by
the bacterium Staphylococcus aureus and the aim of the work presented here was to establish how S. aur-
eus responded following exposure to Ag(I). Exposure of S. aureus to Ag(I) resulted in the release of a range
of proteins from cells. Analysis of proteins released revealed a number of proteins associated with the
stress response (e.g. alkaline shock protein, methionine sulfoxide reductase), virulence (e.g. signal trans-
duction protein) and metabolism (e.g. lipase, acetate kinase, phosphoglycerate mutase). The release of
toxins (e.g. a-hemolysin, bifunctional autolysin, leucocidin F) was decreased. These results indicated that,
while silver is a potent antimicrobial agent, exposure of S. aureus to this metal results in the release of a
variety of proteins from the cell. Many of the proteins showing increased release were antigenic and
would have the potential to induce an inflammatory response at the site of infection and thus delay
healing.
 2013 Elsevier Ltd. All rights reserved.
1. Introduction
The anti-microbial activity of silver has been known for many
years and the Ag(I) ion is the active agent in many healthcare prod-
ucts (Lansdown, 2010). Central venous catheters impregnated with
silver metal particles substantially reduced the incidence of cathe-
ter-associated infections (CAIs) in paediatric patients (Carbon et al.,
1999). Such silver-impregnated catheters have been shown to pre-
vent CAIs through a reduction in bacterial adherence by up to 40%
(Bechert et al., 1999). There is a wide range of wound dressings
incorporating silver available such as hydrogels, creams, foams,
meshes, hydrocolloids and polymeric films (Thomas and McCub-
bin, 2003). Clinical investigations into the anti-bacterial nature of
such silver-containing dressings have revealed the potent activity
against Pseudomonas aeruginosa, vancomycin-resistant Pseudomo-
nas species and methicillin-resistant Staphylococcus aureus (MRSA)
(Ulker et al., 2005; Olsen et al., 2000). Silver has been widely used
in the treatment of S. aureus infections and one of its primary
modes of action has been suggested to involve disruption of bacte-
rial membrane integrity (Randall et al., 2013). Other clinical bene-
fits of silver wound dressings include a reduction in wound
associated pain (Rustogi et al., 2005), increased epithelialisation
of skin grafts (Demling and Desanti, 2002) and increased efficiency
at preventing MRSA colonisation of burn wounds (Honari et al.,
2011). The anti-bacterial nature of the Ag(I) ion has also been
exploited by its incorporation into topical, anti-bacterial agents
such as burn wound creams (e.g. silver sulphadiazine (SSD), silvad-
ene) (Monafo and Freedman, 1987). Initial studies investigating the
activity of silvadene on burn wounds colonised by P. aeruginosa re-
vealed the superior activity of SSD against P. aeruginosa, with the
cream also reducing post-burn destruction of the skin (Fox, 1968).
S. aureus is one of the main pathogens associated with infec-
tions of the skin and soft tissue (Kirby et al., 2002) and it can lead
to more serious conditions such as toxic shock syndrome (TSS),
scalded skin syndrome (SSS) and sepsis (Plano, 2004). Many factors
contribute to the pathogenesis of S. aureus such as the presence of a
capsule, the expression of adhesins, the secretion of various toxins
and also immunomodulators. S. aureus produces a wide variety of
cytotoxins which have potent effects on the cells of the host im-
mune system (Dinges et al., 2000). S. aureus has been shown to
be a very versatile pathogen and has been isolated from both hos-
pital and community-acquired infections (García-Lara et al., 2005).
S. aureus infection can be extremely difficult to control and up to
4% of cases may be fatal (García-Lara et al., 2005). The Ag(I) ion
is highly active against a range of microorganisms through interac-
tions with the cell wall which results in changes in conformation
(Leaper, 2006). This allows the Ag(I) ion to penetrate the cells while
causing cell leakage, denaturation and inactivation of proteins and
essential enzymes, such as RNA- and DNA-ases, ultimately leading
to cell death (Slawson et al., 1990). The action of the Ag(I) ion on
the cell wall has been studied using the yeast Candida albicans
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and it has been shown to bind to cysteine residues of the enzyme,
phosphomannose isomerase (PIM) and inhibit its activity (Lans-
down, 2002). This enzyme plays an important role in cell wall bio-
synthesis (Wells et al., 1995) and inhibition can lead to leakage of
important nutrients, such as phosphates and succinates, from the
cytoplasm (Lansdown, 2006). The inhibitory action of the Ag(I)
ion can be attributed to its strong binding affinity for thiol groups
present in cell respiratory enzymes, its interaction with structural
proteins and its binding with DNA bases which inhibits replication
(Atiyeh et al., 2007).
The aim of the work presented here was to examine the effect of
Ag(I) on the leakage of protein from S. aureus and to characterise
the nature of the released proteins.
2. Materials and methods
2.1. Organism and culture conditions
A clinical S. aureus isolate from an urinary tract infection was
employed. Cultures were grown on nutrient agar plates (Oxoid
Ltd., Basingstoke, Hampshire, England) (28 g/L) at 37 C for 24 h
and kept at 4 C for short-term storage. For liquid culturing, cells
were cultured overnight in an aerated conical flask in an orbital
shaker at 37 C and 200 rpm in nutrient broth (Oxoid Ltd., Basing-
stoke, Hampshire, England) (13 g/L).
2.2. Assessment of protein release from S. aureus
Stationary phase S. aureus cells were harvested by centrifuga-
tion on a Beckmann GS-6 bench centrifuge at 1814g for 5 min.
The cell pellets were washed twice in phosphate buffered saline
(PBS, 5 ml) and resuspended in either dH2O or AgNO3 (3.0 lg/ml
(17.6 lM), Sigma–Aldrich) and incubated at 37 C and 200 rpm
for a further 0.5, 1, 2 or 4 h. A concentration of 3.0 lg/ml was cho-
sen as this had previously been established to be the MIC80 value
(Smith et al., 2012). Cells were harvested as before and the super-
natants collected. The quantity of protein released from the cells
was assayed using the Bradford assay (Bio-Rad), with BSA (Sig-
ma–Aldrich) as standard. The released protein was resolved by 1-
D SDS–PAGE.
2.3. Isolation of released protein for 2D-SDS–PAGE analysis
Stationary phase S. aureus cells were exposed to the Ag(I) ions
(3.0 lg/ml) for 2 h and harvested by centrifugation for 10 min at
1814g in a Beckmann GS-6 centrifuge. The cell pellet was washed
twice with sterile phosphate buffer saline (PBS) and re-suspended
in 2 mls of Lambert’s breaks buffer (10 mM KCl (Sigma–Aldrich),
3 mM NaCl (Sigma–Aldrich), 4 mM MgCl2 (Sigma–Aldrich),
10 mM 1, 4-piperazinediethanesulfonic acid (PIPES) (Sigma–Al-
drich)). In addition, protease inhibitors, at a concentration of
10 lg/ml, were used (Leupeptin, Pepstatin A, Aprotinin and N-a-
p-tosyl-L-lysine chloromethylketone hydrochloride (TLCK)). The
cell suspensions were sonicated with two 10 s blasts using a sonip-
robe sonicator (Bandelin Sonopuls, HD 2200) to dislodge proteins
loosely bound to the cell wall. This resulted in no loss in cell viabil-
ity nor cell lysis (data not presented). The suspension was centri-
fuged at 239g for 4 min at 4 C and the supernatant retained.
Protein was precipitated by the addition of ice-cold acetone and
storing the solutions at 20 C overnight. The precipitated protein
was collected by centrifugation on an Eppendorf 5417R centrifuge
(17,949g for 30 min at 4 C). The acetone was removed and the
pellet allowed to air dry. Protein (300 lg) was separated by 2-D
SDS–PAGE as previously described (Kelly and Kavanagh, 2010).
All gels were performed in triplicate and the mean increase/de-
crease in abundance of protein was calculated.
3. LC/MS mass spectrometry analysis
Protein spots that exhibited altered intensities on 2-D gels of
control and Ag(I)-treated cells were excised, washed and trypsin
digested (Shevchenko et al., 2006). Samples were analysed on a
6340 Ion Trap LC/MS spectrometer (Agilent Technologies) using
bovine serum albumin (BSA) as the external standard. The mass
lists were generated using the search programme http://
www.matrixscience.com and were blasted using the http://exp-
asy.org/sprot/search programme. Mascot score values greater than
68 were considered significant (p < 0.05).
3.1. Statistical analysis
All experiments were performed on three separate occasions.
Multiple comparisons of means were analysed using Fisher’s least
significant different test using PROC GLM of the SAS 9.1 statistical
model. Differences were deemed significant with p 6 0.05.
4. Results
4.1. Assessment of protein release from S. aureus cells as a result of
Ag(I) ion exposure
Cells were exposed to Ag(I) ions as described and the extent of
protein release was monitored by measuring the protein content of
the supernatant (Fig. 1). There was an increase in protein release
from cells exposed to Ag(I) ions which reached a peak at 2 h
(96 ± 1.1 lg/ml in the control, 122 ± 1.1 lg/ml from Ag(I) ion trea-
ted cells (p < 0.001)). The released protein was also resolved by 1D
SDS–PAGE and the resulting gel (Fig. 2) demonstrated that a wide
range of protein is released from S. aureuswhen cells were exposed
to 3.0 lg/ml Ag(I) for 0.5–4 h. The abundance of released proteins
of molecular weight 25 kDa and 50 kDa, for example, reached a
peak at 2 h exposure and thereafter declined.
4.2. Characterisation of changes in protein release following exposure
to Ag(I) ions
S. aureus cells were exposed to Ag(I) ions (3.0 lg/ml) for 2 h as
this had been determined to be the time of maximum protein re-
Fig. 1. The effect of Ag(I) ions on protein release from S. aureus cells. The release of
protein from S. aureus cells, which had been exposed to either water or the MIC80
value of AgNO3 (3.0 lg/ml), for 1, 2 or 4 h, was assessed as described. Differences in
abundance were deemed statistically significant at p < 0.05 (), p < 0.01 () and
p < 0.001 ().
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lease (Figs. 1 and 2) and proteins were recovered from cells as de-
scribed, resolved by 2-D SDS PAGE and stained with colloidal Coo-
massie. A mild sonication step (2  10 s treatments) was employed
to release protein present on the bacterial cell surface but this step
had no effect on viability nor did it result in cell lysis. A total of 22
proteins (Fig. 3) were identified to be altered in abundance in the
supernatant (Tables 1). Of these, 12 were involved in metabolism,
six were involved in virulence and four in the stress response of S.
aureus.
5. Discussion
While silver is now widely used clinically to inhibit the growth
of microbes very little attention has been paid to the response of
microbial cells to exposure to the Ag(I) ion and their attempt to
withstand its effects. It has been demonstrated that metallic
Ag(0) interacted with the peptidoglycan layer of S. aureus cells
and led to the formation of pits (Mirzajani et al., 2011). Exposure
to Ag(0) induced an increase in the abundance of muramic acid
Fig. 2. One-dimensional SDS–PAGE of protein released from S. aureus when exposed to Ag(I) ions for 0.5, 1, 2 or 4 h. Cells were exposed to the silver ions for the stated times
and the protein in the supernatant was resolved by 1-D SDS–PAGE.
Fig. 3. Two-dimensional SDS–PAGE analysis of proteins released by S. aureus cells following exposure to Ag(I) ions for 2 h. Proteins were extracted and separated by 2-D SDS–
PAGE as described. Experiment was performed on three independent occasions and a representative set of gels is shown. (a) Control cells (untreated) and (b) cells incubated
for 2 h in AgNO3 (3.0 lg/ml).
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which is a major component of the peptidoglycan layer. Exposure
of E. coli to Ag(0) nanoparticles caused an increase in the amount
of reducing sugars and proteins released from the cells (Li et al.,
2010). The exposure of C. albicans to Ag(0) nanoparticles promoted
an antifungal effect through disruption of the cell membrane struc-
ture which was assessed by measuring the release of glucose and
trehalose (Kim et al., 2009).
The results of the work presented here demonstrate that expo-
sure to the Ag(I) ion affects the permeability of S. aureus cells as a
significant increase in the release of protein from cells was ob-
served. Protein release is indicative of increased permeability
which can result in osmotic and/or oxidative stress within the cell.
In addition, a variety of proteins associated with metabolism (12),
virulence (6) and the stress response (4) were found to be released
from cells when exposed to AgNO3 for 2 h.
Some of the released proteins were associated with metabolism
and included acetate kinase (spot 2) and succinyl CoA synthetase
(spot 4) which were increased in abundance by 2.1-fold and 1.6-
fold, respectively, following treatment with Ag(I) ions. The pres-
ence of phosphoglycerate mutase (spot 7) increased by 2.1-fold
and this protein was also increased in expression following expo-
sure of E. coli to Zn(II) ions (Sigdel et al., 2006). A number of pro-
teins involved in translation demonstrated elevated levels of
release from cells, including 30S ribosomal protein S2 (spot 5,
1.6-fold), 50S ribosomal protein L25/general stress protein (spot
6, 1.7-fold) and 50S ribosomal protein L31 type B (spot 12, 1.7-
fold), suggesting that either the cells are responding to the Ag(I)
ion by attempting to increase protein biosynthesis or these pro-
teins are leaking from the cell due to altered cellular permeability.
The virulence of S. aureus can be attributed to the expression of
adhesins and to the secretion of toxins (Bernardo et al., 2004). Al-
pha hemolysin (spot 16) is one of the main pore-forming toxins of
S. aureus, allowing the efflux of cellular contents and the influx of
Na+ and Ca2+ into the target cell and causing osmotic swelling
and cell rupture (Dinges et al., 2000). Proteomic analysis identified
a 2.1-fold decrease in the release of alpha hemolysin upon expo-
sure of S. aureus to AgNO3. It was also found that the abundance
of secreted exoproteins, such as alpha- and beta-hemolysin, was
reduced in S. aureus cells after exposure to the antibiotic, linezolid
(Bernardo et al., 2004). Leucocidin F and bifunctional autolysin
were also reduced in expression in Ag(I)-treated S. aureus cells by
1.5 and 1.7-fold, respectively. There was an increase in the re-
lease of the signal transduction protein, TRAP (target of RNAIII-
activating protein) (spot 18), by 3.1-fold from cells exposed to
Ag(I). S. aureus TRAP has been shown to play a key role in regulat-
ing the pathogenesis of bacterial cells by controlling a range of vir-
ulence factors (Balaban et al., 1998; Korem et al., 2005) and in
tolerance to oxidative stress (Kiran and Balaban, 2009). It has been
suggested that TRAP allows S. aureus to adhere to host cells when
cells are at a low density and switches to express toxins in the late
exponential phase thus allowing the organism to establish an
infection (Balaban et al., 2001). The increase in the release of this
protein suggests increased biosynthesis and that S. aureus may be
responding to Ag(I) ion exposure by increasing the regulation of
virulence factors.
Oxidative stress results from an imbalance between the produc-
tion of reactive oxygen species (ROS) and the anti-oxidant defences
which eliminate ROS before damage can occur. The abundance of a
number of proteins involved in the stress response of S. aureuswas
increased upon Ag(I) ion treatment. These included a universal
stress response protein (spot 19, +1.2), an alkaline shock protein
(spot 21, +2.8), a transcription repressor protein (spot 22, +1.6)
and methionine sulphoxide reductase A (spot 20), (MsrA) which
showed a 2.9-fold increase in abundance. The Msr enzyme family
comprises MsrA and MsrB which reduce S-MetO and R-MetO to
methionine (Moskovitz, 2005). MsrA-specific methionine reduc-
tase activity in S. aureus plays a central role in the ability of the cell
to tolerate oxidative stress (Singh and Moskovitz, 2003). Methio-
nine sulfoxide reductase A has been shown to perform a critical
role in the ability of Leishmania major to survive and replicate in
macrophages thus highlighting a role for this enzyme in pathogen-
esis (Sanson et al., 2013). It was also found that this enzyme was
Table 1










1 C5PZ99 Serine hydroxymethyltransferase Metabolic process 517 27% +2.0
2 C8MFH1 Acetate kinase Tricarboxylic acid cycle 1081 61% +2.1
3 Q6GJZ6 Lipase Triglyceride lipase activity 390 20% +2.4
4 P99070 Succinyl-CoA synthetase Tricarboxylic acid cycle 377 27% +1.6
5 P66545 30S ribosomal protein S2 Translation 647 47% +1.6
6 Q7A1s4 50S ribosomal protein L25/general stress protein Translation 464 34% +1.7
7 D2UHN7 Phosphoglycerate mutase Glycolysis 898 78% +2.1
8 Q2G1C0 2-C-methyl-D-erythritol 4-phosphate
cytidylyltransferase
Nucleotidyl-transferase 449 46% +1.5
9 Q7A1R6 Glutamine amidotransferase subunit PdxT Hydrolysis of glutamine to glutamate and
ammonia
693 61% +2.3
19 P67397 Uracil phosphoribosyltransferase Glycosyltransferase 652 65% +1.5
11 P68791 Elongation factor G Protein biosynthesis 365 14% +1.8
12 P66197 50S ribosomal protein L31 type B Translation 166 61% +1.7
Functions in virulence
13 Q53747 Leucocidin F Cytolysis in other organism pathogenesis 98 7% 1.5
14 P63845 Transcriptional repressor CodY Transcription regulation 532 56% +1.6
15 Q5HIU3 ABC transporter ATP-binding 609 41% +1.7
16 P09616 Alpha-hemolysin Pore formation 633 49% 2.1
17 P0Z5Z8 Bifunctional autolysin Cellular cell wall organization 219 10% 1.7
18 Q7A4W3 Signal transduction protein TRAP Major regulator of staphylococcal pathogenesis 187 37% +3.1
Functions in stress
19 Q2FXL6 Putative universal stress protein Response to stress 639 69% +1.2
20 P65446 Methionine sulfoxide reductase A Repair enzyme 254 35% +2.9
21 P0A0P7 Alkaline shock protein 23 Alkaline pH tolerance 466 55% +2.8
22 Q7A1R4 Transcription repressor of class III stress genes-like
protein
Stress response 467 52% +1.6
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induced upon exposure of S. aureus cells to the antibiotic, oxacillin
(Singh et al., 2001). The identification of elevated levels of these
proteins released from S. aureus confirm that cells are experiencing
stress as a result of Ag(I) ion exposure. This also suggests that the
bacterium is attempting to mount a defence in response to the me-
tal ion, which is an important attribute of a successful pathogen
(Baker et al., 2010).
The results presented here indicate that exposure of S. aureus to
Ag(I) ions induces the release of a broad range of proteins. A num-
ber of the released proteins are implicated in the ability of the bac-
terium to tolerate oxidative stress (e.g. TRAP) or play a role in
tissue colonisation (e.g. methionine sulfoxide reductase A), and
are potentially capable of stimulating a strong host immune re-
sponse (Leitner et al., 2011). The widespread use of silver-contain-
ing ointments and plasters in the treatment of burn wounds raises
the possibility of Ag(I) ions interacting with S. aureus at the wound
site and altering its physiology. In addition, the change in the abun-
dance of a range of proteins (TRAP, stress proteins, ABC trans-
porter) may indicate an increase in the virulence of the pathogen
with detrimental consequences for the patient.
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